TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

42.50$ -2.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Scholar Rock Holding Corp (SRRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 524 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRRK
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
33 – – – 62 54 119 109 181 171 197 189 196 176 156 163 388 361 332 298 304 266 424 390 358 315 285 251 311 267 227 179 475 408 340 412 404 535 524
28 28 – – 59 51 117 106 178 162 188 179 185 164 145 119 344 318 290 258 265 229 389 358 328 287 260 228 288 247 199 153 451 385 319 391 385 515 507
10 -28 – – 56 23 115 104 115 67 114 33 36 95 115 56 160 159 207 176 213 100 306 133 103 151 108 68 102 92 93 76 178 138 153 287 324 431 437
– 28 – – 58 48 115 104 176 160 185 176 157 161 141 116 341 315 282 246 253 210 371 344 315 275 249 219 280 238 190 139 437 364 295 370 368 480 492
0.1 – – – 0.4 0.4 – – – – – – 25 25 0.0 0.0 0.0 – – – – – – – 2.7 – – – 1.1 1.1 1.3 1.1 2.2 1.9 2.0 3.5 – – 2.0
– – – – – – 0.0 0.0 – – – – – – – – – – – – – – – – -2.7 – – – – – – – – – – – – – –
2.4 – – – 2.2 2.0 1.9 2.6 3.2 8.7 8.3 9.0 8.6 8.2 7.6 5.6 8.1 8.9 38 9.5 9.6 9.5 8.7 28 7.4 6.7 6.0 – – – – – – – – – – – –
– – – – – – 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – – – 0.0 0.0 – – – – – – – – – – – – – – – – – – – – 4.1 3.7 3.4 3.4 2.4 2.3 2.4 – – – –
4.8 – – – 115 6.8 7.4 6.7 75 73 68 67 83 77 74 100 128 120 115 111 132 95 95 97 98 86 82 83 86 85 93 100 106 95 107 167 159 259 270
3.0 – – – 5.0 5.9 6.7 5.8 31 34 32 33 33 27 33 33 43 70 67 65 64 33 40 34 36 26 24 27 33 38 33 39 47 38 50 62 55 60 72
0.6 1.7 – – 0.6 0.6 0.7 0.6 0.4 1.3 1.1 1.1 1.1 1.2 1.3 4.1 5.4 5.7 7.0 7.2 16 22 27 17 7.9 7.6 7.3 7.2 8.7 13 14 6.0 5.8 5.5 5.2 5.3 5.6 6.1 6.3
0.7 – – – 1.4 3.3 2.6 1.8 3.3 3.2 1.9 3.0 1.1 2.2 2.7 1.1 3.4 2.2 1.6 2.0 4.4 3.0 2.9 2.0 4.0 3.7 3.0 2.0 3.5 2.9 3.3 4.1 10 4.4 1.1 6.8 10 9.2 11
1.0 – – – 0.4 0.2 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 25 25 25 25 48 44 39 50 50 50 50 50 49 45 48 50 50 50 50 100 100 197 196
28 28 – – -54 47 112 102 107 98 129 122 113 99 82 63 261 241 217 187 172 171 330 293 260 229 203 168 225 183 134 79 369 312 233 245 245 276 254
-33 – – – -58 -66 -81 -92 -107 -118 -130 -146 -158 -175 -194 -218 -244 -272 -303 -340 -376 -384 -428 -471 -511 -550 -588 -630 -676 -733 -792 -856 -923 -997 -1,107 -1,210 -1,301 -1,406 -1,516
– 18 18 18 18 24 11 24 26 26 26 29 30 30 30 30 30 36 37 37 37 37 42 79 52 80 80 81 76 96 97 97 100 112 113 114 115 127 131

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?